Chandra Bhagat Pharma Limited has submitted a regulatory certificate to The BSE Limited, addressing the Manager - Listing Compliance, Department of Corporate Service. The communication certifies that the company is exempt from compliance with corporate governance provisions as specified under SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.

The exemption is claimed under Regulation 15 of SEBI LODR Regulations, which states that corporate governance provisions (Regulations 17, 17A, 18, 19, 20, 21, 22, 23, 24, 24A, 25, 26, 27 and clauses (b) to (i) and (t) of sub-regulation (2) of Regulation 46 and para C, D and E of Schedule V) do not apply to:

  • Listed entities with paid-up equity share capital not exceeding ₹10 crore and net worth not exceeding ₹25 crore as on the last day of the previous financial year
  • Listed entities that have listed specified securities on the SME Exchange

The company qualifies for exemption as it has listed its specified securities on the SME Exchange. Consequently, compliance with corporate governance provisions is not applicable to the company, and no Corporate Governance Report is required for the quarter ended 30 September 2026.

The document is signed by a Director of the company and requests the exchange to take this information on record.

#CHANDRA BHAGAT PHARMA LIMITED #SEBIRegulation15 #CorporateGovernanceExemption #SEBIDisclosure #RegulatoryCompliance #Neutral